Home » Topics » Regulatory

Regulatory
RSS

Wyeth-Ayerst and Elan develop new formulation of Lodine

April 11, 1997

Aldara approved in U.S.

April 11, 1997

First launch for new indication of cabergoline

April 11, 1997

Selfadministration device for Imitrex available in the U.S.

April 9, 1997

Pharmacia & Upjohn's Rescriptor cleared by FDA

April 8, 1997

RPR's Tilade approved for pediatric use

April 8, 1997

Human skin equivalent approved in Canada

April 8, 1997

Clinical efficacy and safety of Aphthasol reviewed

April 7, 1997

Court rules in favor of Novopharm regarding generic ranitidine product

April 7, 1997

FDA clears Faulding's generic captopril

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.